4,4,6-Trimethyl-2-(3,3,3-trifluoroprop-1-en-2-yl)-1,3,2-dioxaborinane, 98.0%, 100g

(3aR,8aS)-2-([2,2'-Bipyridin]-6-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole, 98%, 100mg

5-Chloro-7-nitro-1H-indole, 95.0%, 5g

3'-Azido-2'3'-ddCTP, ≥95%, 100 µl, plastic packaging.

2-Methyldihydrothiophen-3(2H)-one, 95.0%, 25g

2-Methylthiazole, 97.0%, 10g

3-Bromo-3-ethylpentane, 97.0%, 250mg

6-Iodo-2(3H)-benzoxazolone, 95%, 100mg

trans-4-(2-(Trifluoromethyl)phenyl)pyrrolidine-3-carboxylic acid hydrochloride, 95.0%, 5g

propan-2-yl 2-hydroxyprop-2-enoate, 95%, 5g

Diquinoxalino[2,3-a:2',3'-c]phenazine>97.0%(T)1g

2-Bromo-1H-pyrrolo[2,3-b]pyridine, 95.0%, 100mg

Methyl 4-chloro-2-formylbenzoate, 97%, 5g